Stem Cell Clinic

Brother-in-law of surf industry fixture who died on medical retreat … – BeachGrit

Ire in the autumn air.

It is October in America, that time of year when Laird Superfood Pumpkin Spice fills the air and baseball the soul. Yes, while the World Surf League may claim to be the nations pastime, baseball has long occupied that slot. The season, which kicks off in spring, consists of 162 games winding through the dog days of summer and culminating in autumn.

The Fall Classic.

Now, in times past, the top three teams from each of the three division, both National and American Leagues, punched their playoff ticket to the playoffs alongside the National and American League team with the best record that didnt win its division as wildcards.

The Major League Baseball powers that be, though, wanted to add some spice and expanded the wildcard portion, allowing a few more teams a shot at the Big Dance. These teams play a three game series, then the winner plays the team with the best record in its league.

This tinkering has been compared to the World Surf Leagues decision to implement Finals Day wherein the top five surfers, male and female, head to Lower Trestles to compete in a winner-take-all showdown.

While the intention was to increase excitement in both baseball and surfing, the results have also benefited upstarts that just so happened to get hot.

Take Stephanie Gilmores worst-to-first 2022 performance in which Carissa Moore, the champion all year, was unseated.

Or, over on the baseball side, the Arizona Diamondbacks sweeping the Los Angeles Dodgers even though the Dodgers were ahead of the D-Backs by sixteen games at season end.

Last year, the Dodgers were undone by the San Diego Padres in similar fashion, leaving Dodger fans furious and wanting the playoff format changed back to the way it was.

Furious.

Message boards and op-eds are filled with salty messages from Dodgers, and Braves, fans decrying the Carissa Moore-ing of teams that proved their worth all season only to get Lower Trestled.

Surf fans not named Richard Toledo nodding quietly.

Will the grousing lead to changes?

Do you have thoughts on the matter or a horse in the race?

The Texas Rangers take on the Houston Astros tonight for the American League pennant.

All action, no lulls.

Read the rest here:
Brother-in-law of surf industry fixture who died on medical retreat ... - BeachGrit

Faeth Therapeutics Announces National Academy of Medicine … – BioSpace

AUSTIN, Texas--(BUSINESS WIRE)-- Faeth Therapeutics, a leader in metabolic oncology research and treatment innovation, proudly announces the induction of its co-founder, Dr. Siddhartha Mukherjee, Assistant Professor at Columbia, Pulitzer Prize Winner, and one of Time 100's Most Influential People, into the esteemed National Academy of Medicine (NAM).

Dr. Mukherjee was honored for contributing important research in the immunotherapy of myeloid malignancies, such as Acute Myeloid Leukemia, for establishing international centers for immunotherapy for childhood cancers, and for the discovery of tissue-resident stem cells. His book, The Emperor of All Maladies, won the Pulitzer Prize and was nominated by Time as among the centurys 100 most influential books, introducing millions to modern cancer research. This recognition accentuates the collective dedication and caliber of Faeth's team and the company's commitment to advancing the realm of cancer care.

With Dr. Mukherjee's recent induction into the National Academy of Medicine, he joins fellow Faeth co-founders who have previously received this honor from the National Academy of Science: Karen Vousden, PhD, Chief Scientist of CRUK, Group Leader at the Crick Institute, and Director at Bristol Myers Squibb; Lew Cantley, PhD, Professor of Cell Biology at the Dana Farber Cancer Institute at Harvard University; Greg Hannon, PhD, Director of CRUK Cambridge Institute; and Scott Lowe, PhD, Chair of Cancer Biology & Genetics at Memorial Sloan Kettering, underlining the depth of Faeth Therapeutics' commitment to scientific excellence and innovation.

"Dr. Mukherjee's induction into the National Academy of Medicine reaffirms Faeth Therapeutics' dedication to unparalleled scientific rigor and innovation. We are immensely proud to have such an impressive team of co-founders driving our mission to redefine and elevate standards in oncology care," said Anand Parikh, J.D., Chief Executive Officer of Faeth Therapeutics.

Mukherjee is one of 100 new members announced by the academy. In the National Academy of Medicine, members are elected by their colleagues as a testament to their exceptional accomplishments. Being inducted into the academy represents one of the most prestigious accolades within the realm of medicine.

About Faeth Therapeutics

Faeth Therapeutics is a clinical-stage biotechnology company focused on bringing breakthrough research in metabolic oncology into the clinic. The company leverages its machine-learning platform to identify therapeutic programs that combine traditional therapeutics and a dietary metabolic regimen to enhance outcomes, with the goal of transforming the treatment landscape. Lead asset, FTH-001, combines serabelisib and an insulin-suppressing regimen to slow tumor growth via PI3K pathway inhibition. Faeths scientific founders include industry leaders Drs. Lew Cantley, Sid Mukherjee, Karen Vousden. For additional information, visit http://www.faeththerapeutics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231013531071/en/

The rest is here:
Faeth Therapeutics Announces National Academy of Medicine ... - BioSpace